PatSnap is built for patent searches. Sleuth builds your landscape, with the programs found only in patents next to the ones in the clinic and the company behind each one.
Sleuth builds landscapes, target assessments, and partner searches, and reads patents from the US, Europe, Japan, China, and WIPO as it goes. A program found only in a patent shows up with its owner and the deals around it.
Landscapes, target and indication assessments, and partner searches, with the programs found only in patents included.
Your IP team runs freedom-to-operate, prior-art, and claim searches.
Sleuth
PatSnap
Sleuth
Strategy calls: landscapes, target and indication assessments, and partner and asset searches.
PatSnap
Patent work. Its own site lists it as best suited for “IP Professionals,” running novelty searches, FTO searches, and patent drafting.
Sleuth
Rows in your landscape, next to the programs in the clinic, each linked to its patent.
PatSnap
Patents you search one query at a time. You pull out the programs and build the landscape yourself.
Sleuth
The developer’s pipeline, partners, funding, and deals, linked to every program.
PatSnap
The assignee on each patent. The company’s partners and deals are in a separate database.
Sleuth
The standard fields, plus any column you ask for. Ask “who holds the rights outside the US?” and Sleuth fills it in for every program.
PatSnap
The fields PatSnap tracks, the same for every user.
Sleuth
Sleuth scores programs on your criteria and builds the deck, spreadsheet, or interactive analysis.
PatSnap
You search, filter, and export, then build the analysis yourself.
Sleuth
Click any value to see the patent, filing, or registry entry behind it, with its date, a confidence score, and whether it’s sourced, inferred, or unknown.
PatSnap
You check the patents and records yourself.
Sleuth
The drugs, trials, companies, and deals you’d look up in a pipeline database, included in every plan.
PatSnap
Built around patents. Its drug database is sold as a separate product.
Sleuth reads patent filings from the US, Europe, Japan, China, and WIPO, and turns the programs they disclose into rows. Each one shows up next to the programs in the clinic, with its patent as the source.
“Which in-vivo cell therapy programs from China are in development, including ones disclosed only in patents, and when was each first made public?”
A program disclosed only in a patent gets its own row, named for its target, with its developer and phase.
Click a date to open the patent or registry entry behind it.
Saved to your Studio account, and exported to Excel, a deck, or an interactive analysis.
Sleuth links every program to its developer’s pipeline, partners, and funding, and to 200K+ licensing, M&A, and financing deals. Ask “who holds the rights outside the US?” and it’s a column, filled in for every program.
Our quarterly reports are built in Sleuth, so preclinical programs are in the count, not just the ones in the clinic.
332 programs mapped. Most of China’s 161 are still preclinical, and some are known only by a patent number.
Next-generation ADCs are mostly preclinical and China-led. 62 originate in China, and none of the 20 US programs has reached the clinic.
About 3,150 oligonucleotide programs, and most of the work beyond the liver is still preclinical.
Keep PatSnap if your IP team runs freedom-to-operate, prior-art, and claim searches. For landscapes and partner searches, Sleuth has the patents you need.
PatSnap’s own pitch is “Check novelty and freedom to operate before you commit.” That check belongs with your IP team.
The searches your team runs before it files its own patents.
Drafting claims and answering office actions with your counsel.
Yes, for anyone making strategy calls: landscapes, target and indication assessments, and partner searches, with the programs found only in patents included. Keep PatSnap if your IP team runs freedom-to-operate, prior-art, and claim searches.
Patents and applications from the US, European, Japanese, and Chinese patent offices, and international filings through WIPO. Sleuth also has the FDA’s Orange Book patents and exclusivity dates, Paragraph IV challenges, and Purple Book patent lists for biologics. Each patent is linked to its drugs, targets, and companies.
Sleuth reads each patent family and records the drugs, targets, and companies it discloses. A program that appears only in a patent becomes a row in the landscape, with the patent as its source.
No. Sleuth tells you which programs exist, who owns them, and when exclusivity ends on approved drugs. Freedom-to-operate opinions and claim searches belong with your IP team and a tool like PatSnap.
PatSnap’s drug database lists drugs, trials, and deals that you search, filter, and export. Sleuth builds the dataset for your question, adds the columns your decision depends on, and builds the analysis on top.
Yes. Sleuth works in Claude, ChatGPT, and Copilot on every plan, and every project is saved to your Studio account.